Development of controlled release silicone adhesive–based mupirocin patch demonstrates antibacterial activity on live rat skin against Staphylococcus aureus
Sheba R David,1 Nurafiqah Malek,1 Abdul Hanif Mahadi,2 Srikumar Chakravarthi,3 Rajan Rajabalaya1 1PAPRSB Institute of Health Sciences, Universiti Brunei Darussalam, Bandar Seri Begawan, Brunei Darussalam; 2Centre for Advanced Material and Energy Sciences (CAMES), Universiti Brunei Darussalam, Banda...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-03-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/development-of-controlled-release-silicone-adhesive-based-mupirocin-pa-peer-reviewed-article-DDDT |
id |
doaj-13c4b8201b114a26932dd556e12b3619 |
---|---|
record_format |
Article |
spelling |
doaj-13c4b8201b114a26932dd556e12b36192020-11-24T23:24:06ZengDove Medical PressDrug Design, Development and Therapy1177-88812018-03-01Volume 1248149437124Development of controlled release silicone adhesive–based mupirocin patch demonstrates antibacterial activity on live rat skin against Staphylococcus aureusDavid SRMalek NMahadi AHChakravarthi SRajabalaya RSheba R David,1 Nurafiqah Malek,1 Abdul Hanif Mahadi,2 Srikumar Chakravarthi,3 Rajan Rajabalaya1 1PAPRSB Institute of Health Sciences, Universiti Brunei Darussalam, Bandar Seri Begawan, Brunei Darussalam; 2Centre for Advanced Material and Energy Sciences (CAMES), Universiti Brunei Darussalam, Bandar Seri Begawan, Brunei Darussalam; 3School of Medicine, Perdana University, Jalan MAEPS Perdana, Serdang, Selangor, Malaysia Background: Peritonitis is the most serious complication of peritoneal dialysis. Staphylococcus aureus infections could lead to peritonitis which causes reversal of peritoneal dialysis treatment back to hemodialysis. The aim of this study was to develop a controlled release silicone adhesive-based mupirocin patch for prophylactic effect and analyze its antibacterial effectiveness against S. aureus.Methods: The matrix patches were prepared by using different polymers, with and without silicone adhesive, dibutyl sebacate and mupirocin. The patches were characterized for mechanical properties, drug content, moisture content, water absorption capacity and Fourier transform infrared spectrum. In vitro release studies were performed by using Franz diffusion cell. In vitro disk diffusion assay was performed on the Mueller–Hinton Agar plate to measure the zone of inhibition of the patches. The in vivo study was performed on four groups of rats with bacterial counts at three different time intervals, along with skin irritancy and histopathologic studies. Results: The patches showed appropriate average thickness (0.63–1.12 mm), tensile strength (5.08–10.08 MPa) and modulus of elasticity (21.53–42.19 MPa). The drug content ranged from 94.5% to 97.4%, while the moisture content and water absorption capacities at two relative humidities (75% and 93%) were in the range of 1.082–3.139 and 1.287–4.148 wt%, respectively. Fourier transform infrared spectra showed that there were no significant interactions between the polymer and the drug. The highest percentage of drug release at 8 hours was 47.94%. The highest zone of inhibition obtained was 28.3 mm against S. aureus. The in vivo studies showed that the bacterial colonies were fewer at 1 cm (7×101 CFU/mL) than at 2 cm (1.3×102 CFU/mL) over a 24-hour period. The patches were nonirritant to the skin, and histopathologic results also showed no toxic or damaging effects to the skin. Conclusion: The in vitro and in vivo studies indicated that controlled release patches reduced the migration of S. aureus on the live rat skin effectively, however, a longer duration of study is required to determine the effectiveness of the patch on a suitable peritonitis-induced animal model. Keywords: transdermal delivery, matrix patch, peritonitis, antibacterial, dialysis infection, histopathologyhttps://www.dovepress.com/development-of-controlled-release-silicone-adhesive-based-mupirocin-pa-peer-reviewed-article-DDDTTransdermal deliverymatrix patchperitonitisStaphylococcus aureussilicone adhesivehistopathology |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
David SR Malek N Mahadi AH Chakravarthi S Rajabalaya R |
spellingShingle |
David SR Malek N Mahadi AH Chakravarthi S Rajabalaya R Development of controlled release silicone adhesive–based mupirocin patch demonstrates antibacterial activity on live rat skin against Staphylococcus aureus Drug Design, Development and Therapy Transdermal delivery matrix patch peritonitis Staphylococcus aureus silicone adhesive histopathology |
author_facet |
David SR Malek N Mahadi AH Chakravarthi S Rajabalaya R |
author_sort |
David SR |
title |
Development of controlled release silicone adhesive–based mupirocin patch demonstrates antibacterial activity on live rat skin against Staphylococcus aureus |
title_short |
Development of controlled release silicone adhesive–based mupirocin patch demonstrates antibacterial activity on live rat skin against Staphylococcus aureus |
title_full |
Development of controlled release silicone adhesive–based mupirocin patch demonstrates antibacterial activity on live rat skin against Staphylococcus aureus |
title_fullStr |
Development of controlled release silicone adhesive–based mupirocin patch demonstrates antibacterial activity on live rat skin against Staphylococcus aureus |
title_full_unstemmed |
Development of controlled release silicone adhesive–based mupirocin patch demonstrates antibacterial activity on live rat skin against Staphylococcus aureus |
title_sort |
development of controlled release silicone adhesive–based mupirocin patch demonstrates antibacterial activity on live rat skin against staphylococcus aureus |
publisher |
Dove Medical Press |
series |
Drug Design, Development and Therapy |
issn |
1177-8881 |
publishDate |
2018-03-01 |
description |
Sheba R David,1 Nurafiqah Malek,1 Abdul Hanif Mahadi,2 Srikumar Chakravarthi,3 Rajan Rajabalaya1 1PAPRSB Institute of Health Sciences, Universiti Brunei Darussalam, Bandar Seri Begawan, Brunei Darussalam; 2Centre for Advanced Material and Energy Sciences (CAMES), Universiti Brunei Darussalam, Bandar Seri Begawan, Brunei Darussalam; 3School of Medicine, Perdana University, Jalan MAEPS Perdana, Serdang, Selangor, Malaysia Background: Peritonitis is the most serious complication of peritoneal dialysis. Staphylococcus aureus infections could lead to peritonitis which causes reversal of peritoneal dialysis treatment back to hemodialysis. The aim of this study was to develop a controlled release silicone adhesive-based mupirocin patch for prophylactic effect and analyze its antibacterial effectiveness against S. aureus.Methods: The matrix patches were prepared by using different polymers, with and without silicone adhesive, dibutyl sebacate and mupirocin. The patches were characterized for mechanical properties, drug content, moisture content, water absorption capacity and Fourier transform infrared spectrum. In vitro release studies were performed by using Franz diffusion cell. In vitro disk diffusion assay was performed on the Mueller–Hinton Agar plate to measure the zone of inhibition of the patches. The in vivo study was performed on four groups of rats with bacterial counts at three different time intervals, along with skin irritancy and histopathologic studies. Results: The patches showed appropriate average thickness (0.63–1.12 mm), tensile strength (5.08–10.08 MPa) and modulus of elasticity (21.53–42.19 MPa). The drug content ranged from 94.5% to 97.4%, while the moisture content and water absorption capacities at two relative humidities (75% and 93%) were in the range of 1.082–3.139 and 1.287–4.148 wt%, respectively. Fourier transform infrared spectra showed that there were no significant interactions between the polymer and the drug. The highest percentage of drug release at 8 hours was 47.94%. The highest zone of inhibition obtained was 28.3 mm against S. aureus. The in vivo studies showed that the bacterial colonies were fewer at 1 cm (7×101 CFU/mL) than at 2 cm (1.3×102 CFU/mL) over a 24-hour period. The patches were nonirritant to the skin, and histopathologic results also showed no toxic or damaging effects to the skin. Conclusion: The in vitro and in vivo studies indicated that controlled release patches reduced the migration of S. aureus on the live rat skin effectively, however, a longer duration of study is required to determine the effectiveness of the patch on a suitable peritonitis-induced animal model. Keywords: transdermal delivery, matrix patch, peritonitis, antibacterial, dialysis infection, histopathology |
topic |
Transdermal delivery matrix patch peritonitis Staphylococcus aureus silicone adhesive histopathology |
url |
https://www.dovepress.com/development-of-controlled-release-silicone-adhesive-based-mupirocin-pa-peer-reviewed-article-DDDT |
work_keys_str_mv |
AT davidsr developmentofcontrolledreleasesiliconeadhesivendashbasedmupirocinpatchdemonstratesantibacterialactivityonliveratskinagainststaphylococcusaureus AT malekn developmentofcontrolledreleasesiliconeadhesivendashbasedmupirocinpatchdemonstratesantibacterialactivityonliveratskinagainststaphylococcusaureus AT mahadiah developmentofcontrolledreleasesiliconeadhesivendashbasedmupirocinpatchdemonstratesantibacterialactivityonliveratskinagainststaphylococcusaureus AT chakravarthis developmentofcontrolledreleasesiliconeadhesivendashbasedmupirocinpatchdemonstratesantibacterialactivityonliveratskinagainststaphylococcusaureus AT rajabalayar developmentofcontrolledreleasesiliconeadhesivendashbasedmupirocinpatchdemonstratesantibacterialactivityonliveratskinagainststaphylococcusaureus |
_version_ |
1725561861136449536 |